CLNNWClene Inc.

Partial data

NAS · US · Healthcare · Biotechnology · clene.com

—Mkt Cap: —P/E: —274d ago

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is be…

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)214.00K $

Gross Profit157.00K $

Net Income (TTM)-26.17M $

Revenue/Share0.0230 USD

Last Price—

Fiscal Year End—

MR Quarter—

Employees75

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-0.00

EPS (TTM)—

EPS (Forward)—

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin78.50%

Oper. Margin-37653.33%

EBITDA Margin0.00%

Profit Margin-13086.50%

ROE148.78%

ROA-144.35%

Growth

Revenue Growth-82.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-18.55M $

CapEx (TTM)39.00K $

FCF Margin-6212.79%

FCF Yield—

Net Debt13.39M $

Net Debt/EBITDA-0.59

Balance Sheet

Debt/Equity-1.23

Current Ratio1.53

Quick Ratio1.02

Book Value/Sh-1.2090 USD

Cash/Share0.7670 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float7.76M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta0.79

S&P 52W Chg15.96%

Avg Vol (30d)—

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

CLNNWClene Inc.

Industry Peers

Key Statistics